Cutia Therapeutics (2487.HK)

HKD 4.56

(0.22%)

Net Debt Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual net debt in 2023 was -229.36 Million CNY , up 44.29% from previous year.
  • Cutia Therapeutics's latest quarterly net debt in 2024 Q2 was -65.71 Million CNY , up 81.76% from previous quarter.
  • Cutia Therapeutics reported annual net debt of -411.73 Million CNY in 2022, down -133.15% from previous year.
  • Cutia Therapeutics reported annual net debt of -176.59 Million CNY in 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported quarterly net debt of -65.71 Million CNY for 2024 Q2, up 81.76% from previous quarter.
  • Cutia Therapeutics reported quarterly net debt of -229.36 Million CNY for 2023 FY, up 44.29% from previous quarter.

Annual Net Debt Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Net Debt of Cutia Therapeutics (2023 - 2021)

Year Net Debt Net Debt Growth
2023 -229.36 Million CNY 44.29%
2022 -411.73 Million CNY -133.15%
2021 -176.59 Million CNY 0.0%

Peer Net Debt Comparison of Cutia Therapeutics

Name Net Debt Net Debt Difference
Uni-Bio Science Group Limited -76.36 Million HKD -200.338%
CK Life Sciences Int'l., (Holdings) Inc. 5.26 Billion HKD 104.355%